Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by ttboy29on May 22, 2018 8:21pm
65 Views
Post# 28066701

RE:RE:RE:Financing Closing?

RE:RE:RE:Financing Closing?
CBDInvestor wrote: I think it's unfortunate, but I bet management will cave and give better terms if they ask for it, instead of pulling the entire deal, releasing financials early for a rebound and going in for another round later on. Sit on 4-5% interest and finance using debt, equity does not seem like the way to go. Interest rates should be taken advantage of....... silly mgmt. Instead of 5% per year interest were bleeding 5% share price per day lol. Cmon.
spock9 wrote: With the price dropping below 0.73, the fund might ask for better terms. It seems after each financing, the SP drops 20% below. Hopefully we bounce off quickly from 60s otherwise there is no real support until 30s and that would be a full cycle back to 2017 baseline. Hard to make sense what happened to the SP other than massive dilution from the insiders. In the AGM booklet back in Feb., there was a CDO (somthing like that) entity controlling 130 million shares and not listed as insiders but what are they? Still hold a small postion but not expecting much SP movement perhaps until next year.

I don't think this is situation where they cave. The financing was supposed to close on May 11th and on May 11th the price closed at 74 cents. Maybe this delay has something to do with Anson no longer being involved. 

 




Bullboard Posts